{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:21:54Z","timestamp":1793294514955,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012432.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000}}],"reference-count":124,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012432.pub3","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T13:48:50Z","timestamp":1658670530000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Interventions for managing medication-related osteonecrosis of the jaw"],"prefix":"10.1002","volume":"2022","author":[{"given":"Natalie H","family":"Beth-Tasdogan","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology of Natural Products & Clinical Pharmacology; Ulm University; Ulm Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry; Ulm University; Ulm Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Diagnosis, and Periodontology; Faculty of Dentistry, Cairo University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zolk","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Immanuel Klinik R\u00fcdersdorf; Brandenburg Medical School Theodor Fontane; R\u00fcdersdorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Uwe","family":"Peter","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Immanuel Klinik R\u00fcdersdorf; Brandenburg Medical School Theodor Fontane; R\u00fcdersdorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0002|cit2","unstructured":"Randomized controlled trial of hyperbaric oxygen in patients who have taken bisphosphonates clinicaltrials.gov\/show\/NCT00462098"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.joms.2017.10.024","article-title":"Can autofluorescence guide surgeons in the treatment of medication-related osteonecrosis of the jaw? A prospective feasibility study","volume":"76","author":"Giudice","year":"2018","journal-title":"Journal of Oral Maxillofacial Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"issue":"6","key":"10.1002\/14651858.CD012432.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jbspin.2011.04.017","article-title":"A dental extraction protocol with plasma rich in growth factors (PRGF) in patients on intravenous bisphosphonate therapy: a case-control study","volume":"786","author":"Mozzati","year":"2011","journal-title":"Joint, Bone, Spine"},{"issue":"9","key":"10.1002\/14651858.CD012432.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","article-title":"Tooth extraction in patients on zoledronic acid therapy","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012432.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jbspin.2011.04.018","article-title":"Tooth extraction and oral bisphosphonates: comparison of different surgical protocol","volume":"78","author":"Mozzati","year":"2011","journal-title":"Joint, Bone, Spine"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00198-012-2239-8","article-title":"Tooth extraction in osteoporotic patients taking oral bisphosphonates","volume":"24","author":"Mozzati","year":"2013","journal-title":"Osteoporosis International"},{"issue":"10","key":"10.1002\/14651858.CD012432.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jcms.2016.07.026","article-title":"Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - a prospective study over 6 years","volume":"44","author":"M\u00fccke","year":"2016","journal-title":"Journal of Cranio-maxillo-facial Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00198-019-05199-w","article-title":"A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration","volume":"31","author":"Ohbayashi","year":"2020","journal-title":"Osteoporosis International"},{"issue":"6","key":"10.1002\/14651858.CD012432.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","article-title":"Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw?","volume":"75","year":"2017","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jcms.2020.02.006","article-title":"Tooth extractions in patients under antiresorptive therapy for osteoporosis: primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw","volume":"48","author":"Poxleitner","year":"2020","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijom.2016.10.008","article-title":"Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study","volume":"46","author":"Ristow","year":"2017","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0014|cit14","unstructured":"Comparison of two different mucosal closure techniques after tooth extraction in high risk patients with antiresortive medication intake - a prospective, randomized, blinded feasebility [sic] study trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00010106"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/odi.13556","article-title":"Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake-A randomized pilot trial","volume":"27","author":"Ristow","year":"2020","journal-title":"Oral Diseases"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0016|cit16","unstructured":"Does teriparatide reverse osteonecrosis of the jaw? trialsearch.who.int\/?TrialID=ACTRN12612000950864"},{"issue":"26","key":"10.1002\/14651858.CD012432.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled, randomized trial","volume":"38","author":"Sim","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0018|cit18","unstructured":"Surgical management of medication related osteonecrosis of the jaws with concentrated growth factor clinicaltrials.gov\/ct2\/show\/NCT04531800"},{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1007\/s00784-020-03766-8","article-title":"The effect of concentrated growth factor (CGF) in the surgical treatment od medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study","volume":"25","author":"Y\u00fcce","year":"2021","journal-title":"Clinical Oral Investigations"},{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","article-title":"Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study","volume":"21","author":"Asaka","year":"2017","journal-title":"Clinical Oral Investigations"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0021|cit21","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"Journal of the Canadian Dental Association"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00774-014-0566-x","article-title":"Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases","volume":"33","author":"Bramati","year":"2015","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10534-018-0081-y","article-title":"Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study","volume":"31","author":"Calvani","year":"2018","journal-title":"Biometals"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oooo.2017.10.015","article-title":"Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw","volume":"125","author":"Colapinto","year":"2018","journal-title":"Oral Surgery, Oral Medicine Oral Pathology and Oral Radiology"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0025|cit25","first-page":"151","article-title":"Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients","volume":"26","author":"Coviello","year":"2012","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0026|cit26","first-page":"2477","article-title":"Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates","volume":"34","author":"DE Iuliis","year":"2014","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012432.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.enfcli.2017.04.001","article-title":"Intervention to improve awareness of the risk factors for osteonecrosis of the jaw in patients under treatment with bisphosponates. Randomised clinical trial","volume":"27","author":"Garcia-Martinez","year":"2017","journal-title":"Enfermeria Clinica"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0029|cit29","first-page":"248","article-title":"Autofluorescence as indicator for detecting the surgical margins of medication-related osteonecrosis of the jaws","volume":"65","author":"Giovannacci","year":"2016","journal-title":"Minerva stomatologica"},{"issue":"12","key":"10.1002\/14651858.CD012432.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: a preliminary study","volume":"32","author":"Jung","year":"2017","journal-title":"Journal of Bone and Miner Research"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"166\u201372","DOI":"10.1016\/j.jfma.2012.04.010","article-title":"Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws","volume":"113","author":"Lee","year":"2014","journal-title":"Journal of the Formosan Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","article-title":"Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management","volume":"104","author":"Montebugnoli","year":"2007","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/medicina57020145","article-title":"Complementarity of photo-biomodulation, surgical treatment, and antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)","volume":"57","author":"Nica D","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0034|cit34","first-page":"e320\u20136","article-title":"Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide","volume":"19","author":"Pelaz","year":"2014","journal-title":"Medicina Oral, Patologia Oral y Cirugia Bucal"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012432.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijom.2019.03.314","article-title":"Low level laser therapy as coadjuvant in bisphosphonate related osteonecrosis of the jaws: a pilot study","volume":"48","author":"Rodriguez","year":"2019","journal-title":"International Journal of Oral & Maxillofacial Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","article-title":"The effect of platelet-rich fibrin membrane in surgical therapy of medication-related osteonecrosis of the jaw","volume":"78","author":"Szentpeteri","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"101\u201313","DOI":"10.1007\/s10103-009-0687-y","article-title":"Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)","volume":"25","author":"Vescovi","year":"2010","journal-title":"Lasers in Medical Science"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"Article ID 5854","DOI":"10.1155\/2012\/585434","article-title":"Surgical approach and laser applications in BRONJ osteoporotic and cancer patients","volume":"2012","author":"Vescovi","year":"2012","journal-title":"Journal of Osteoporosis"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"e0244859","DOI":"10.1371\/journal.pone.0244859","article-title":"Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: a subgroup analysis by disease stage","volume":"16","author":"Watanabe","journal-title":"PLOS One [electronic resource]"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0040|cit40","unstructured":"Clinical study of modified curettage for medication-related osteonecrosis of the jaw www.chictr.org.cn\/showproj.aspx?proj=45608"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0041|cit41","unstructured":"Treatment strategies for medication-related osteonecrosis of the jaw - a prospective, partially randomized patient preference trial www.who.int\/trialsearch\/Trial2.aspx?TrialID=DRKS00012888"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0042|cit42","unstructured":"Investigation of the preventive effects of antimicrobial penetrated collargen plug(TERUPLUG) for post-extraction tooth socket for osteonecrosis of the jaw after tooth extraction in patients using high-dose antiresorptive agent [sic] rctportal.niph.go.jp\/en\/detail?trial_id=jRCTs071200006"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0043|cit43","unstructured":"Assessment of platelet rich fibrin efficiency on healing delay and on jawbone osteochemonecrosis provoked by bisphosphonates (OCN\/PRF) clinicaltrials.gov\/ct2\/show\/record\/NCT01526915"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0044|cit44","unstructured":"Prospective randomized study: assessment of PRF efficacy in prevention of jaw osteonecrosis after tooth extraction (PRF) clinicaltrials.gov\/ct2\/show\/record\/NCT02198001"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0045|cit45","unstructured":"Pentoxifylline and Tocopherol (PENTO) in the treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) clinicaltrials.gov\/show\/nct03040778"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0046|cit46","unstructured":"Use of topical phenytoin in bisphosphonate-related osteonecrosis of the mandible clinicaltrials.gov\/ct2\/show\/NCT03269214"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0047|cit47","unstructured":"Plasma rich in growth factors for treatment of medication related osteonecrosis of the jaw clinicaltrials.gov\/show\/nct03390777"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0048|cit48","unstructured":"Best Treatment Choice for Osteonecrosis of the Jaw (BETCON) clinicaltrials.gov\/ct2\/show\/NCT04512638"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0049|cit49","unstructured":"Surgical management of medication related osteonecrosis of the jaws with concentrated growth factor clinicaltrials.gov\/ct2\/show\/NCT04531800"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0050|cit50","unstructured":"Study to the effect of teriparatide formulation Forteo versus Teribon on bisphosphonate-related osteonecrosis of the jaw in osteoporosis patients upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000010706&language=E"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0051|cit51","unstructured":"The clinical effect of teriparatide on BRONJ (bisphosphonate-related osteonecrosis of the jaw) https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000042862"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jrsm.6","article-title":"Graphical displays for meta-analysis: an overview with suggestions for practice","volume":"1","author":"Anzures-Cabrera","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"36","key":"10.1002\/14651858.CD012432.pub3-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma","volume":"26","author":"Badros","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"551\u20134","DOI":"10.1016\/j.oraloncology.2009.01.002","article-title":"Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ). A concise update","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncology"},{"issue":"34","key":"10.1002\/14651858.CD012432.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005005.pub4","article-title":"Hyperbaric oxygen therapy for late radiation tissue injury","author":"Bennett","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"lancet. Diabetes & Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clinical Oral Implants Research"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2334\/josnusd.21-0016","article-title":"Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics","volume":"63","author":"Cabras","year":"2021","journal-title":"Journal of Oral Science"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.reuma.2012.05.005","article-title":"Systematic literature review of bisphosphonates and osteonecrosis of the jaw in patients with osteoporosis","volume":"9","author":"Chamizo Carmona","year":"2013","journal-title":"Reumatolog\u00eda Clinica"},{"issue":"7-8","key":"10.1002\/14651858.CD012432.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000447372","article-title":"Safety of denosumab versus zoledronic acid in patients with bone metastases: a meta-analysis of randomized controlled trials","volume":"39","author":"Chen","year":"2016","journal-title":"Oncology Research and Treatment"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4615-0651-5_10","article-title":"Assessment of bone quality, quantity and turnover with multiple methodologies at multiple skeletal sites","volume":"496","author":"Chestnut","year":"2001","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-011-1429-y","article-title":"Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II\/III breast cancer","volume":"127","author":"Coleman","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.4317\/jced.53504","article-title":"Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review","volume":"9","author":"Comas-Calonge","year":"2017","journal-title":"Journal of cCinical and Experimental Dentistry"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1467-9876.2008.00650.x","article-title":"The radial plot in meta-analysis: approximations and applications","volume":"58","author":"Copas","year":"2009","journal-title":"Journal of the Royal Statistical Society: Series C (Applied Statistics)"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0066|cit66","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"General Dentistry"},{"issue":"12","key":"10.1002\/14651858.CD012432.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1002\/hed.25944","article-title":"Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review.","volume":"41","author":"Souza Tolentino","year":"2019","journal-title":"Head Neck"},{"issue":"16","key":"10.1002\/14651858.CD012432.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.3390\/ijerph18168432","article-title":"The treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): a systematic review with a pooled analysis of only surgery versus combined protocols","volume":"18","author":"Di Fede","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"7","key":"10.1002\/14651858.CD012432.pub3-BIB0069|cit69","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related ssteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral and Maxillofacial Surgery Clinics of North America"},{"issue":"8","key":"10.1002\/14651858.CD012432.pub3-BIB0071|cit71","first-page":"1","article-title":"Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.","volume":"32","author":"Dos Santos","year":"2021","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0072|cit72","first-page":"2313","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem","volume":"31","author":"Eckardt","year":"2011","journal-title":"Anticancer Research"},{"issue":"7109","key":"10.1002\/14651858.CD012432.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"Journal of Cranio-maxillo-facial Surgery"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD012432.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","article-title":"Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Freiberger","year":"2009","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2013.06.192","article-title":"Early Inhibitory effects of zoledronicacid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein","volume":"72","author":"Gerard","year":"2014","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012432.pub3-BIB0078|cit78","first-page":"2662","article-title":"Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review","volume":"25","author":"Goker","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"115676","DOI":"10.1016\/j.bone.2020.115676","article-title":"Adjuvant therapies for MRONJ: a systematic review.","volume":"141","author":"Govaerts","year":"2020","journal-title":"Bone"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0080|cit80","unstructured":"GRADEpro GRADE Working Group, McMaster University 2014"},{"issue":"11","key":"10.1002\/14651858.CD012432.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"Journal of the American Dental Association"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8529(02)00024-5","article-title":"Summary of meta-analysis of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures","volume":"31","author":"Guyatt","year":"2002","journal-title":"Endocrinology Metabolism Clinics of North America"},{"issue":"9","key":"10.1002\/14651858.CD012432.pub3-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"7414","key":"10.1002\/14651858.CD012432.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0086|cit86","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0088|cit88","volume-title":"Assessment of Osteoporosis at the Primary Health-care Level. Technical Report","volume":"66","author":"Kanis","year":"2007"},{"issue":"4","key":"10.1002\/14651858.CD012432.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"Journal of Dental Research"},{"issue":"8","key":"10.1002\/14651858.CD012432.pub3-BIB0090|cit90","first-page":"3527","article-title":"Quality of life in breast cancer patients with bisphosphonate-related osteonecrosis of the jaws and patients with head and neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires","volume":"32","author":"Kyrgidis","year":"2012","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","article-title":"Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases","volume":"33","author":"Lee","year":"2007","journal-title":"Journal of Oral Imlantology"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0092|cit92","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (eds).\u00a0 Cochrane Handbook for Systematic Reviews of Interventions \u00a0Version 6.3\u00a0(updated February\u00a02022). Cochrane, 2022.\u00a0 Available from\u00a0www.training.cochrane.org\/handbook."},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2753.2009.01203.x","article-title":"Bisphosphonate-associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study","volume":"16","author":"Lopez-Jornet","year":"2010","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"8","key":"10.1002\/14651858.CD012432.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1067\u201372","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review","volume":"44","author":"Lopez-Jornet","year":"2016","journal-title":"Journal of Cranio-maxillo-facial Surgery"},{"issue":"11","key":"10.1002\/14651858.CD012432.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00520-012-1563-z","article-title":"Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis","volume":"20","author":"Lopez-Olivo","year":"2012","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncology"},{"issue":"9","key":"10.1002\/14651858.CD012432.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1115\u20137","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10549-009-0432-z","article-title":"Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis","volume":"116","author":"Mauri","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"issue":"22","key":"10.1002\/14651858.CD012432.pub3-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.14219\/jada.archive.2010.0229","article-title":"How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care","volume":"141","author":"Migliorati","year":"2010","journal-title":"Journal of the American Dental Association"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"issue":"9757","key":"10.1002\/14651858.CD012432.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","article-title":"First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial","volume":"376","author":"Morgan","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40780-015-0035-2","article-title":"Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events","volume":"22","author":"Nakamura","year":"2015","journal-title":"Journal of Pharmaceutical Health Care and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/mabs.1.3.8592","article-title":"Denosumab","volume":"1","author":"Pageau","year":"2009","journal-title":"MAbs"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bdj.2015.680","article-title":"New cancer therapies and jaw necrosis","volume":"219","author":"Patel","year":"2015","journal-title":"British Dental Journal"},{"issue":"9","key":"10.1002\/14651858.CD012432.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3324\/haematol.11096","article-title":"Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients","volume":"92","author":"Petrucci","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0108|cit108","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008455.pub2","article-title":"Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)","author":"Rollason","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012432.pub3-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.joms.2014.04.031","article-title":"Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"4","author":"Ruggiero","year":"2007","journal-title":"Clinical Cases in Mineral and Bone Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD012432.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0115|cit115","unstructured":"Scottish Dental Clinical Effectiveness Programme Oral Health Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw Dundee, UK SDCEP"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"192320","DOI":"10.1155\/2014\/192320","article-title":"Bisphosphonate-related osteonecrosis of the jaw: a review of the literature","volume":"2014","author":"Sigua-Rodriguez","year":"2014","journal-title":"International Journal of Dentistry"},{"key":"10.1002\/14651858.CD012432.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","article-title":"Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases","volume":"67","author":"Stanton","year":"2009","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"9","key":"10.1002\/14651858.CD012432.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.joms.2006.05.042","article-title":"Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?","volume":"64","author":"Vescovi","year":"2006","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0119|cit119","first-page":"142","article-title":"Bisphosphonates and osteonecrosis: an open matter","volume":"9","author":"Vescovi","year":"2012","journal-title":"Clinical Cases in Mineral and Bone Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012432.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ebd.6401110","article-title":"Priority oral health research identification for clinical decision-making","volume":"16","author":"Worthington","year":"2015","journal-title":"Evidence-Based Dentistry"},{"issue":"5","key":"10.1002\/14651858.CD012432.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.3747\/co.20.1497","article-title":"Denosumab and giant cell tumour of bone\u2014a review and future management considerations","volume":"20","author":"Xu","year":"2013","journal-title":"Current Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012432.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jbmr.2693","article-title":"Osteonecrosis of the jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS)","volume":"31","author":"Zhang","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"issue":"11","key":"10.1002\/14651858.CD012432.pub3-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw (MRONJ)","author":"Beth-Tasdogan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012432.pub3-BIB0124|cit124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012432.pub2","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:17:45Z","timestamp":1767194265000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012432.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Oral Health Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":124,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012432.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}